Journal of Applied & Environmental Microbiology
ISSN (Print): 2373-6747 ISSN (Online): 2373-6712 Website: Editor-in-chief: Sankar Narayan Sinha
Open Access
Journal Browser
Journal of Applied & Environmental Microbiology. 2014, 2(3), 65-69
DOI: 10.12691/jaem-2-3-1
Open AccessArticle

Validation of A Rapid Tuberculosis PCR Assay for Detection of MDR-TB Patients In Sohag University Hospital

Ahmed Hassan1, Mona Fattouh1, , Iman Atteya1, Hamdi Mohammadeen2 and Hydi Ahmed3

1Departments of Medical Microbiology and Immunology, Sohag Faculty of Medicine, Sohag University

2Departments of Chest Diseases, Sohag Faculty of Medicine, Sohag University

3Departments of Clinical pathology, Sohag Faculty of Medicine, Sohag University

Pub. Date: March 18, 2014

Cite this paper:
Ahmed Hassan, Mona Fattouh, Iman Atteya, Hamdi Mohammadeen and Hydi Ahmed. Validation of A Rapid Tuberculosis PCR Assay for Detection of MDR-TB Patients In Sohag University Hospital. Journal of Applied & Environmental Microbiology. 2014; 2(3):65-69. doi: 10.12691/jaem-2-3-1


The aim of this work was to evaluate the value of polymerase chain reaction (PCR) in rapid detection of resistance to rifampin and isoniazid in TB patients. Sixty sputum specimens were collected from MDR-TB patients. In addition to 10 sputum samples from TB patients who were responders to treatment by first line anti-TB drugs. The isolates were identified, cultured and tested for detection of multidrug resistance mutations in ropB gene coding for RIF resistance and katG gene coding for INH resistance using PCR; and were compared to Lowenstein Jensen (LJ) culture drug susceptibility testing (DST) using the Proportion method as the ‘gold standard’. By using proportion method on LJ all 60 sputum samples of MDR patients were resistant to both INH and RIF. By PCR; rpoB gene coding for RIF resistance was detected in 59 clinical isolates. The sensitivity and specificity of mutation of rpoB gene for the 60 specimens were 98.3% and 100% respectively. katG gene coding for INH resistance was detected in 56 clinical isolates. The sensitivity and specificity of mutation of KatG gene for the 60 specimens were 93.3 % and 100 % respectively. The 10 sputum samples of TB patients who were responders to treatment were susceptible to first-line anti-TB drugs on LJ culture DST and no MDR genes were detected by PCR. Our study demonstrated that PCR analysis was rapid, sensitive and specific approach for detection of rpoB and katG genes within 48 hours, which is more rapid than drug susceptibility testing after the culture.

Multidrug-resistant Mycobacterium tuberculosis polymerase chain reaction (PCR) rpoB katG

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit


[1]  Chanda M, Allan C, and Innocent C. Low occurrence of tuberculosis drug resistance among pulmonary tuberculosis patients from an urban setting, with a long-running DOTS program in Zambia.2010. Tuberculosis Research and Treatment, vol. 2010, Article ID 938178, 6 pages, 2010.
[2]  Hillemann D, Gerdes RS, and Richter E. Evaluation of Genotype MTBDR plus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens. J Clin Microbiol 2007;45:2635e40.
[3]  Huang H, Jin Q, Ma Y, Chen X, and Zhuang Y. Characterization of rpoB mutations in rifampicin-resistant Mycobacterium tuberculosis isolated in China. Tuberculosis (Edinburgh).2002, 82(2-3): 79-83.
[4]  Kent P T and Kubica G P. Public health mycobacteriology: a guide for the level III laboratory, p. 64-68. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, Atlanta, GA.1985.
[5]  Kocagoz T, Saribas Z, and Alp A. Rapid determination of rifampin resistance in clinical isolates of Mycobacterium tuberculosis by real-time PCR. J. Clin. Microbiol.2005, 43(12): 6015-60.
[6]  Koch R. Die Aetiologie der Tuberculosis. Berl. Klinische Wochenschr.1882, 100(12): 539.
[7]  Lavender C, Globan M, Sievers A, Jacobe HB, and Fyfe J. Molecular characterization isoniazid-resistant Mycobacterium tuberculosis isolates collected in Australia. Antimicrob. Agents. Chemother.2005, 49(10): 4068-4074.
[8]  Loddenkemper R, and Hauer B. Drug-Resistant Tuberculosis. Dtsch. Arztebl. Int.2010, 107(1-2): 10-19.
[9]  Migliori GB, Matteelli A, Cirillo D, and Pai M. Diagnosis of multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis: Current standards and challenges. Can J Infect Dis Med Microbiol.2008; 19(2):169-172.
[10]  Mokrousov I, Narvskaya O, Otten T, Limeschenko E, Steklova L and Vyshnevskiy B. High prevalence of KatG Ser315Thr substitution among isoniazid-resistant Mycobacterium tuberculosis clinical isolates from northwestern Russia, 1996 to 2001. Antimicrob Agents Chemother.2002; 46, 1417-1424.
[11]  Pai M, Minion J, and Sohn H. Novel and improved technologies for tuberculosis diagnosis: progress and challenges. Clin Chest Med.2009; 30: 701-716.
[12]  Paramasivan CN and Venkataraman P. Drug resistance in 5. tuberculosis in India. Indian J Med Res.2004; 120 : 377-86.
[13]  Piatek A S, Telenti A, Murray M R, El-Hajj H, Jacobs W R, Kramer F R and Alland D. Genotypic analysis of Mycobacterium tuberculosis in two distinct populations using molecular beacons: implications for rapid susceptibility testing. Antimicrob Agents Chemother.2002; 44, 103-110.
[14]  Sahm D, and Weissfeld F. Bailey and Scott’s diagnostic microbiology. (11th ed.). St. Louis, MO7 Mosby, pp 3-29.2002.
[15]  Schneider E, and Castro KG. Tuberculosis trends in the United States, 1992-2001. Tuberculosis (Edinb) 83:21-29.2003.
[16]  Sethi S, Sharma S, and Sharma SK. Drug susceptibility of Mycobacterium tuberculosis to primary antitubercular drugs by nitrate reductase assay. Indian J Med Res.2004; 120:468-471.
[17]  Sharma SK and Mohan A. Multidrug-resistant tuberculosis: a 2. menace that threatens to destabilize tuberculosis control. Chest.2006; 130: 261-72.
[18]  Singla R, Sarin R, and Khalid UK. Seven-year DOTS-Plus pilot experience in India: results, constraints and issues. Int J Tuberc Lung Dis.2009; 13: 976-81.
[19]  World Health Organization. WHO Report 2011: Global Tuberculosis Control. (2011) Available: en/. Accessed 2012 Oct 20.
[20]  World Health Organization. Country cooperation strategy at a glance. Available at: / country focus / cooperation_strategy /ccsbrief_egy_en.pdf.2009.
[21]  World Health Organization. Global Tuberculosis Control - A short update to the 2009 report.
[22]  World Health organization. Tuberculosis country profiles.2011. Available at :
[23]  Yang S, Zhong M, Zhang Y and Wang Y. Rapid detection of rpoB and katG genes from the sputum of multidrug-resistant Mycobacterium tuberculosis by polymerase chain reaction (PCR)-direct sequencing analysis. African Journal of Microbiology Research. 2011; 5(26), 4519-4523.
[24]  Yang Z, Durmaz R, Yang D, Gunal S, Zhang L, Foxman B, Sanic A, and Marrs CF. Simultaneous detection of isoniazid, rifampin, and ethambutol resistance of Mycobacterium tuberculosis by a single multiplex allele-specific polymerase chain reaction (PCR) assay. Diagnostic Microbiology and Infectious Diseas;.2005, 53; 201-208.
[25]  Yue J, Shi W, Xie J, Li Y, Zeng E and Wang H. Mutations in the rpoB gene of multidrug-resistant Mycobacterium tuberculosis isolates from China. J Clin Microbiol. 2003;41, 2209-2212.